DeepRhythmAI

by Medicalgorithmics S.A.  · Based in Poland →Revolutionizing cardiac arrhythmia diagnostics with AI-powered ECG analysis.
Cardiology

Enterprise
Regulatory Status Disclosed

Overview

DeepRhythmAI (DRAI) by Medicalgorithmics S.A. is a cutting-edge, cloud-based artificial intelligence solution designed to significantly enhance the accuracy and efficiency of cardiac arrhythmia detection and classification from electrocardiogram (ECG) data. This device-agnostic platform leverages advanced deep learning techniques, including Convolutional Neural Networks (CNNs) and Transformer models, to analyze multichannel ECG signals with unparalleled precision.

Trained on an extensive dataset of over 250 billion annotated heartbeats, DeepRhythmAI demonstrates superior performance compared to traditional manual analysis. Independent studies have shown that DRAI can reduce the risk of missed clinically meaningful rhythm disturbances by 14 to 114 times, directly impacting patient safety and diagnostic reliability. It is capable of identifying a wide spectrum of arrhythmias, such as atrial fibrillation, ventricular tachycardia, complete heart block, and pauses, providing physicians with comprehensive and reliable insights.

DeepRhythmAI is engineered to streamline clinical workflows, potentially reducing the workload for ECG technicians by up to 65% and enabling faster diagnoses. Its architecture supports seamless integration with existing healthcare systems and various ECG monitoring devices, including Holter, Extended Holter, Event Monitoring, and Mobile Cardiac Telemetry. The platform offers direct-to-physician reporting capabilities, making it a powerful advisory tool for qualified healthcare professionals in conjunction with their clinical expertise and patient history.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered arrhythmia detection and classification
  • Utilizes CNN and Transformer models
  • Trained on 250 billion+ annotated heartbeats
  • Device-agnostic and integrates with various ECG devices
  • Cloud-based software
  • Faster ECG reporting and analysis
  • Reduces missed diagnoses (14x to 114x fewer)
  • Streamlines clinical workflows (up to 65% efficiency increase)
  • Direct-to-physician reporting capabilities
  • Scalable Application Programming Interface (API) for integration

Use Cases

  • Autonomous analysis of ambulatory ECGs
  • Detection of critical arrhythmias (e.g., atrial fibrillation, complete heart block, ventricular tachycardia)
  • Support for Holter, Extended Holter, Event Monitoring, and Mobile Cardiac Telemetry data analysis
  • Predicting atrial fibrillation risk
  • Reducing technician workload in ECG analysis
  • Improving patient safety through enhanced diagnostic accuracy

What Physicians Need to Know

ECG/EKG Analysis Capability
DeepRhythmAI (DRAI) is an FDA-cleared, cloud-based AI engine that leverages deep learning (Convolutional Neural Networks and Transformer models) for accurate and rapid analysis of multichannel ECG data. It processes data from Holter, Extended Holter, Event Monitoring, and Mobile Cardiac Telemetry devices, providing results in minutes.
Arrhythmia Detection Accuracy
DRAI demonstrates superior sensitivity in detecting heart rhythm disorders, with the DRAI MARTINI study showing a 14 times lower risk of missed diagnoses of critical arrhythmias compared to human technicians. It achieved 99.5% sensitivity for indication-relevant tachyarrhythmias and 99.4% for syncope/bradycardia, and a 99.9% negative predictive value for ruling out critical arrhythmias.
Heart Failure Risk Prediction
The DeepRhythmAI platform can predict the likelihood of atrial fibrillation, a significant risk factor for heart failure. Research indicates that 24-hour ECG monitoring analyzed by DeepRhythmAI can predict the chance of developing atrial fibrillation over a 30-day period.
Cardiac Monitoring Integration
DeepRhythmAI is designed for seamless integration with third-party software and various ECG recording devices, including Holter, Event recorders, and Mobile Cardiac Telemetry. It operates as a cloud-based solution with a scalable Application Programming Interface (API).
AHA/ACC Guideline Alignment
The groundbreaking DRAI MARTINI study, which validated DeepRhythmAI's performance, was presented at the American Heart Association (AHA) 2026 meeting, indicating alignment with major cardiology organizations.
Real-Time Alert Capability
DeepRhythmAI functions as an AI engine for accurate, real-time heart rhythm analysis, delivering results rapidly to enhance diagnostic efficiency. While DeepRhythmAI itself is not an ECG alarm device, its integration into platforms like the DeepRhythm Platform can enable timely notifications for clinicians.
Physician Tip

Leverage DeepRhythmAI for significantly faster and more accurate arrhythmia detection in ambulatory ECG recordings, potentially reducing missed diagnoses by a factor of 14 compared to traditional technician analysis. Integrate this AI solution into existing workflows to streamline the diagnostic process, reduce workload, and enable more confident direct-to-physician reporting for ruling out critical arrhythmias. While DeepRhythmAI is highly effective for ECG analysis, remember that it serves as an advisory tool and its interpretations should be confirmed in conjunction with clinical context and other diagnostic information. For cardiac CT/MRI analysis or coronary artery assessment, consider Medicalgorithmics' complementary VCAST solution.

DeepRhythmAI is a cloud-based, device-agnostic solution with a scalable API, facilitating seamless integration with various third-party ECG analysis software and devices such as Holter monitors, event recorders, and mobile cardiac telemetry systems. This allows for enhanced data flow, improved workflow efficiency, and consolidated patient data within existing healthcare infrastructures. It does not have a native user interface and is intended for integration into external visualization and reporting software used by healthcare professionals.

Details

Category Cardiology AI, Clinical Decision Support & Reference
Pricing Enterprise Unknown
DeploymentCloud
Mobile AppNone
API Available Yes
Data Export Yes
LanguagesEnglish
Target SizeSolo to large health systems
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Cleared AI-estimated — K253141 (March 6, 2026)
Integrations
EHR Not specified
Specialties Cardiology

Social Proof

CustomersNumerous healthcare providers globally
Notable
Wellysis (Samsung spin-off)DMS-Servicem-Health Solutions

What the Web Says

DeepRhythmAI (DRAI) is an FDA-cleared, AI-powered, cloud-based software developed by Medicalgorithmics for rapid and accurate ECG analysis, specifically designed to enhance arrhythmia detection and diagnosis efficiency. Studies have shown that DRAI can significantly reduce missed diagnoses of severe arrhythmias compared to human technicians, with one study reporting 14 times fewer missed diagnoses. The system is intended to support healthcare professionals by providing analysis results for review and confirmation, rather than replacing a physician's clinical decision.

Overall: Positive

Strengths

  • Significantly higher sensitivity in detecting heart rhythm disorders compared to human specialists.
  • 14 times fewer missed diagnoses of severe arrhythmias.
  • Reduces false negative findings in arrhythmia detection.
  • Cloud-based for scalable and remote monitoring capabilities.
  • Automated ECG interpretation and workflow automation to minimize manual reviews.
  • Hardware-agnostic, allowing integration with various ECG devices.

Limitations

  • Higher frequency of false positives compared to human analysis.
  • Does not replace a physician's clinical decision; results require review and confirmation by qualified medical personnel.
  • Lack of a primary user interface, requiring integration with external visualization software.
  • Potential medico-legal questions regarding liability in case of false negatives if used for triage without immediate physician review.
  • No specific pricing details publicly available; requires contacting the vendor.

Based on reviews from: HealthAidb, EurekAlert!, PHRI, Faculty of Medicine, Lund University, Practical Patient Care, X-ray Interpreter, MoneyController, BioWorld, ResearchGate, accessdata.fda.gov, Reddit

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate DeepRhythmAI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
MEDICALGORITHMICS secures FDA approval for DeepRhytmAI technology
Medicalgorithmics received FDA approval in the U.S. for its DeepRhythmAI, a cloud-based AI algorithm for ECG signal analysis that classifies a wide range of arrhythmia disorders. This technology aims to provide quicker and more accurate patient diagnoses with reduced human involvement.
2022-08
Medicalgorithmics (via PR Newswire)
DRAI MARTINI: Artificial Intelligence Beats Human Readers at Arrhythmia Detection
New research presented at the ESC Congress 2024, the DRAI MARTINI study, revealed that DeepRhythmAI (DRAI) has significantly higher sensitivity than human specialists in detecting heart rhythm disorders on long ECG recordings, missing diagnoses 14 times less often.
2024-09
PHRI (Population Health Research Institute)
AI could safely replace human analysis of ambulatory ECG
An international study led by PHRI Associate Investigator Linda Johnson found that DeepRhythmAI analysis of long-term ECG recordings surpassed human technicians, with 14 times fewer missed diagnoses of severe arrhythmias. The findings were published in Nature Medicine.
2024-09
Citeline
Revving up AI for ECG: Regulatory and reimbursement breakthroughs in 2024
Medicalgorithmics gained FDA approval for its DeepRhythm Platform (DRP) in June 2024, a cloud-based platform incorporating its DeepRhythmAI algorithms for arrhythmia diagnostics. This highlights a year of significant regulatory approvals for AI ECG algorithms.
2024-12
Poland Insight
Medicalgorithmics Signs AI Diagnostic Software Contract with Leading UK Provider
Medicalgorithmics signed an agreement to provide its DeepRhythmAI algorithms and DRP platform to the largest private Independent Diagnostic Testing Facility (IDTF) in the United Kingdom, marking its 19th client in 2025.
2025-11
Lund University Faculty of Medicine
AI is better than humans at analyzing long-term ECG recordings
A study published in Nature Medicine, co-led by Associate Professor Linda Johnson, demonstrated that Medicalgorithmics' DeepRhythmAI algorithm, trained on millions of heartbeats, led to 14 times fewer missed diagnoses of severe arrhythmias compared to human technicians.
2025-02
Zenicor Medical Systems AB
Zenicor Integrates Advanced AI for Arrhythmia Diagnostics
Zenicor Medical Systems AB is integrating Medicalgorithmics' DeepRhythmAI into its ECG analysis platform to enhance arrhythmia diagnostics, aiming for faster, safer, and more accurate results by reducing staff time on ECG interpretation.
2025-09
Wellysis
Wellysis Signs Strategic Partnership with Medicalgorithmics SA
Wellysis partnered with Medicalgorithmics S.A. to integrate its FDA-cleared S-Patch wearable ECG device with Medicalgorithmics' DeepRhythm Platform (DRP) and DeepRhythmAI algorithms, aiming for more precise, real-time patient data analysis.
2025-05

Videos

Product demos, reviews, and walkthroughs for DeepRhythmAI.

View all on YouTube

Frequently Asked Questions

DeepRhythmAI is designed for seamless integration with most electronic health record (EHR) systems and existing ECG devices, often through API connections or dedicated software plugins. It aims to provide analysis results directly within your patient's digital chart for easy access and review, streamlining the diagnostic process.
DeepRhythmAI is undergoing rigorous clinical validation and is actively pursuing necessary regulatory clearances, such as FDA approval and CE Mark certification, to ensure its safety and efficacy for clinical use. Physicians should verify its current regulatory status before deployment in their practice.
DeepRhythmAI employs robust encryption protocols, de-identification techniques, and adheres strictly to international data privacy regulations like HIPAA and GDPR. Patient data is processed securely, and access is restricted to authorized personnel only, maintaining the highest level of confidentiality.
DeepRhythmAI leverages advanced deep learning algorithms for enhanced accuracy in detecting subtle arrhythmias and complex cardiac patterns that might be missed by conventional methods or other AI tools. Its unique strength lies in its ability to provide predictive insights and personalized risk assessments, offering a more comprehensive view.
DeepRhythmAI typically offers tiered subscription models based on usage volume or specific feature sets, including per-analysis fees or comprehensive institutional licenses. Specific pricing details are available upon consultation with our sales team to tailor a plan that best fits your practice's needs and scale.
While highly accurate, DeepRhythmAI is intended as a diagnostic aid and does not replace the critical judgment and expertise of a qualified physician. Its limitations may include performance variations with poor quality ECGs or rare arrhythmias not extensively represented in its training data, requiring clinical correlation.

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.